Recurrent Primitive Neuroectodermal Tumor: Clinical Trials

1 trial for Recurrent Primitive Neuroectodermal Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Recurrent Primitive Neuroectodermal Tumor: new trials by email Literature Review of Recurrent Primitive Neuroectodermal Tumor trials Research Report on Recurrent Primitive Neuroectodermal Tumor

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
Bevacizumab, Irinotecan Hydrochloride, Temozolomide - Central Nervous System Neoplasm, Pineoblastoma
Phase 2CompletedNational Cancer Institute (NCI)1082010-11-222021-07-23

Narrower conditions

Central Nervous System Neoplasms (1)  ·  Medulloblastoma (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Neuroectodermal Tumors, Primitive, Peripheral (1)  ·  Pinealoma (1)

Broader conditions

Brain Diseases (1)  ·  Brain Neoplasms (1)  ·  Central Nervous System Diseases (1)  ·  Glioma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neuroectodermal Tumors (1)

Interventions

Bevacizumab (1)  ·  Disulfides (1)  ·  Immunoglobulin G (1)  ·  Irinotecan (1)  ·  Temozolomide (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  Puerto Rico (1)  ·  United States (1)

Top investigators

Adam S Levy (1)

NIH funding

U10CA098543 (1), U10CA180886 (1)